Literature DB >> 31893524

Environmental influences on clonal hematopoiesis.

Katherine Y King1, Yun Huang2, Daisuke Nakada3, Margaret A Goodell4.   

Abstract

Clonal hematopoiesis (CH) has emerged as an important factor linked to adverse health conditions in the elderly. CH is characterized by an overrepresentation of genetically distinct hematopoietic stem cell clones in the peripheral blood. Whereas the genetic mutations that underlie CH have been closely scrutinized, relatively little attention has been paid to the environmental factors that may influence the emergence of one dominant stem cell clone. As there is huge individual variation in latency between acquisition of a genetic mutation and emergence of CH, environmental factors likely play a major role. Indeed, environmental stressors such as inflammation, chemotherapy, and metabolic syndromes are known to affect steady-state hematopoiesis. To date, epidemiologic studies point toward smoking and prior chemotherapy exposure as likely contributors to some forms of CH, though the impact of other environmental factors is also being investigated. Mechanistic studies in murine models indicate that the role of different environmental factors in CH emergence may be highly specific to the mutation that marks each stem cell clone. For instance, recent studies have found that clones with mutations in the PPM1D gene are more resistant to genotoxic stress induced by chemotherapy. These clones thus have a competitive advantage in the setting of chemotherapy, but not in other types of stress. Here we review currently available literature on the interplay between environment and the genetic landscapes in CH and highlight critical areas for future study. Improved understanding of the effects of environmental stress on emergence of CH with mutation-specific clarity will guide future efforts to provide preventive medicine to individuals with CH.
Copyright © 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31893524      PMCID: PMC7103536          DOI: 10.1016/j.exphem.2019.12.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  77 in total

Review 1.  Adapting to obesity with adipose tissue inflammation.

Authors:  Shannon M Reilly; Alan R Saltiel
Journal:  Nat Rev Endocrinol       Date:  2017-08-11       Impact factor: 43.330

2.  Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.

Authors:  Qicong Shen; Qian Zhang; Yang Shi; Qingzhu Shi; Yanyan Jiang; Yan Gu; Zhiqing Li; Xia Li; Kai Zhao; Chunmei Wang; Nan Li; Xuetao Cao
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

3.  Chronic exposure to a TLR ligand injures hematopoietic stem cells.

Authors:  Brandt L Esplin; Tomoyuki Shimazu; Robert S Welner; Karla P Garrett; Lei Nie; Qingzhao Zhang; Mary Beth Humphrey; Qi Yang; Lisa A Borghesi; Paul W Kincade
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

4.  Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration.

Authors:  Thomas H Ambrosi; Antonio Scialdone; Antonia Graja; Sabrina Gohlke; Anne-Marie Jank; Carla Bocian; Lena Woelk; Hua Fan; Darren W Logan; Annette Schürmann; Luis R Saraiva; Tim J Schulz
Journal:  Cell Stem Cell       Date:  2017-03-16       Impact factor: 24.633

Review 5.  The bone marrow niche for haematopoietic stem cells.

Authors:  Sean J Morrison; David T Scadden
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

6.  Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.

Authors:  Lambert Busque; Jay P Patel; Maria E Figueroa; Aparna Vasanthakumar; Sylvie Provost; Zineb Hamilou; Luigina Mollica; Juan Li; Agnes Viale; Adriana Heguy; Maryam Hassimi; Nicholas Socci; Parva K Bhatt; Mithat Gonen; Christopher E Mason; Ari Melnick; Lucy A Godley; Cameron W Brennan; Omar Abdel-Wahab; Ross L Levine
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

7.  Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders.

Authors:  Tomoya Muto; Goro Sashida; Motohiko Oshima; George R Wendt; Makiko Mochizuki-Kashio; Yasunobu Nagata; Masashi Sanada; Satoru Miyagi; Atsunori Saraya; Asuka Kamio; Genta Nagae; Chiaki Nakaseko; Koutaro Yokote; Kazuya Shimoda; Haruhiko Koseki; Yutaka Suzuki; Sumio Sugano; Hiroyuki Aburatani; Seishi Ogawa; Atsushi Iwama
Journal:  J Exp Med       Date:  2013-11-11       Impact factor: 14.307

8.  Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms.

Authors:  A C Herman; D A Monlish; M P Romine; S T Bhatt; S Zippel; L G Schuettpelz
Journal:  Blood Cancer J       Date:  2016-06-17       Impact factor: 11.037

9.  DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.

Authors:  Xiaotian Zhang; Jianzhong Su; Mira Jeong; Myunggon Ko; Yun Huang; Hyun Jung Park; Anna Guzman; Yong Lei; Yung-Hsin Huang; Anjana Rao; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2016-07-18       Impact factor: 38.330

10.  PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.

Authors:  Joanne I Hsu; Tajhal Dayaram; Ayala Tovy; Etienne De Braekeleer; Mira Jeong; Feng Wang; Jianhua Zhang; Timothy P Heffernan; Sonal Gera; Jeffrey J Kovacs; Joseph R Marszalek; Christopher Bristow; Yuanqing Yan; Guillermo Garcia-Manero; Hagop Kantarjian; George Vassiliou; P Andrew Futreal; Lawrence A Donehower; Koichi Takahashi; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2018-11-01       Impact factor: 24.633

View more
  18 in total

1.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.

Authors:  Lambert Busque; Maxine Sun; Manuel Buscarlet; Sami Ayachi; Yassamin Feroz Zada; Sylvie Provost; Vincent Bourgoin; Luigina Mollica; Marlies Meisel; Reinhard Hinterleitner; Bana Jabri; Marie-Pierre Dubé; Jean-Claude Tardif
Journal:  Blood Adv       Date:  2020-06-09

2.  FOXO activity adaptation safeguards the hematopoietic stem cell compartment in hyperglycemia.

Authors:  Vinothini Govindarajah; Jung-Mi Lee; Michael Solomon; Bryan Goddard; Ramesh Nayak; Kalpana Nattamai; Hartmut Geiger; Nathan Salomonis; Jose A Cancelas; Damien Reynaud
Journal:  Blood Adv       Date:  2020-11-10

3.  Clonal hematopoiesis: mechanisms driving dominance of stem cell clones.

Authors:  Grant A Challen; Margaret A Goodell
Journal:  Blood       Date:  2020-10-01       Impact factor: 22.113

Review 4.  Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis.

Authors:  Jennifer M SanMiguel; Kira Young; Jennifer J Trowbridge
Journal:  Exp Hematol       Date:  2020-09-28       Impact factor: 3.084

5.  Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Authors:  Anacélia Matos; Silvia M M Magalhães; Michael J Rauh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.

Authors:  Juan Bautista Menendez-Gonzalez; Neil P Rodrigues
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Preleukemic and leukemic evolution at the stem cell level.

Authors:  Jacob Stauber; John M Greally; Ulrich Steidl
Journal:  Blood       Date:  2021-02-25       Impact factor: 22.113

8.  Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative.

Authors:  Bernhard Haring; Alexander P Reiner; Jingmin Liu; Deirdre K Tobias; Eric Whitsel; Jeffrey S Berger; Pinkal Desai; Sylvia Wassertheil-Smoller; Michael J LaMonte; Kathleen M Hayden; Alexander G Bick; Pradeep Natarajan; Joshua S Weinstock; Patricia K Nguyen; Marcia Stefanick; Michael S Simon; Charles B Eaton; Charles Kooperberg; JoAnn E Manson
Journal:  J Am Heart Assoc       Date:  2021-02-23       Impact factor: 5.501

9.  TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.

Authors:  Dariush Nasrollahzadeh; Gholamreza Roshandel; Tiffany Myriam Delhomme; Patrice Hodonou Avogbe; Matthieu Foll; Farrokh Saidi; Hossein Poustchi; Masoud Sotoudeh; Reza Malekzadeh; Paul Brennan; James Mckay; Pierre Hainaut; Behnoush Abedi-Ardekani
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 10.  Therapeutic Targeting of the Leukaemia Microenvironment.

Authors:  Vincent Kuek; Anastasia M Hughes; Rishi S Kotecha; Laurence C Cheung
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.